Medical Supplies

7930 Arjons Drive
92126 San Diego, CA
USA

Phone: 001-858-566-6990
Fax: 001-858-566-9590
http://www.abopharmaceuticals.com
aboinc@aol.com

Company Figures
Number of employees 1-19
Sales volume 10-49 Mio US $
Export content max. 25%
Year of foundation 1990
Area of business Diagnostics

About us
We specialize in Human Plasma, Plasma Derivatives, Vaccines, “Hard to Find” and Specialty Products.

Established in 1979, ABO is headquarted in San Diego, California. In 1998 ABO expanded to Orange County, California. ABO has been successfully providing outstanding customer service to a diversified range of customers including; Hospitals, Physicians, Clinics, Pharmacies, Surgery Centers, OBGYN’s and Manufacturers of Pharmaceutical and Diagnostic Products. In addition ABO Pharmaceuticals, serving as an Authorized Distributor of multiple product lines, drop ships products through McKesson Wholesale.

ABO provides brand and generic pharmaceuticals including; Albumin, IVIG, Coagulation Factors, Vaccines, Cyanide Antidote Kits and other Specialty Pharmaceuticals. In addition, due to ABO’s relationships with major manufacturers and wholesalers world wide, our Procurement Specialists have unsurpassed success in supplying your Hard To Find Product needs.

ABO Pharmaceuticals goal is to establish long term relationships with our valued customers and provide them with secure and safe procurement of products at competitive prices.

Product Information
03.02.10 Controls / Standards / Calibrators immunochemistry
Albumin (Human)

Albumin (Human) 25%, Albuminar®-25 is a sterile aqueous solution of

albumin obtained from large pools of adult human venous plasma by low

temperature controlled fractionation according to the Cohn process. It is

stabilized with 0.02 M sodium acetyltryptophanate and 0.02 M sodium

caprylate and pasteurized at 60°C for 10 hours.

Albumin (Human) 5% Solution

DESCRIPTION

Albumin (Human) 5% solution, AlbuRx™ 5 is a sterile aqueous solution for intravenous administration

containing the albumin component of human blood.

This product is prepared from the plasma of US donors. The product has been produced by alcohol fractionation

and has been heated for 10 hours at 60°C for inactivation of infectious agents. The results of

virus validation studies have shown that the manufacturing process, particularly alcohol fractionation, eliminates

enveloped and non-enveloped viruses. Additionally, heat treatment at 60°C for a period of 10 hours

efficiently inactivates viruses. The solution contains 130–160 milliequivalents of sodium per liter (mEq/L)

and the potassium content is not over 2 mEq/L. The aluminum content does not exceed 200 ?g/L. The

solution is stabilized with 0.08 millimole of sodium acetyltryptophanate plus 0.08 millimole of sodium

caprylate per gram of albumin. The solution contains no preservative.

Link to further Information

Coagulation Factor IX

Coagulation Factor IX (Human), Mononine®, is a sterile, stable, lyophilized concentrate of Factor IX prepared

from pooled human plasma and is intended for use in therapy of Factor IX deficiency, known as Hemophilia

B or Christmas disease. Mononine® is purified of extraneous plasma-derived proteins, including Factors II,
VII and X, by use of immunoaffinity chromatography. A murine monoclonal antibody to Factor IX is used as

an affinity ligand to isolate Factor IX from the source material. Factor IX is then dissociated from the monoclonal

antibody, recovered, purified further, formulated and provided as a sterile, lyophilized powder. The

immunoaffinity protocol utilized results in a highly pure Factor IX preparation. It shows predominantly a single

component by SDS polyacrylamide electrophoretic evaluation and has a specific activity of not less than

190 Factor IX units per mg total protein.

Link to further Information

03.03.06 Haematology reagents

03.03.09 Immunohaematology (Blood grouping)

03.03.09.04 Control material for immunohaematology

03.03.09.05 Reagents for immunohaematology

03.05.02 Hepatitis Viruses

03.05.02.01 Infections desease antigens